. Autosomal dominant mutations in COMP (OMIM 132400), MATN3 (OMIM 607078), COL9A1 (OMIM 120210), COL9A2 (OMIM 600204), and COL9A3 (OMIM 600969) account for the molecular basis of disease in ∼70-75% of the cases (Jackson et al., 2012) . These genes encode structural proteins of the cartilage extracellular matrix (ECM) that are selectively expressed in the tissue (Zaucke, 2009) . A clinically distinct recessive form of the disease (rMED), which results from homozygosity or compound heterozygosity for mutations in SLC26A2 (OMIM 226900), is characterized by epiphyseal dysplasia at the hips, advanced carpal ossification, and a double-layered patella that can be observed on a lateral X-ray of the knee. This rMED phenotype accounts for about 10-15% of MED cases (Superti-Furga et al., 1999) , but may be higher in some populations (Jackson et al., 2012) . SLC26A2 encodes a widely expressed sulfate transporter that imports inorganic sulfate into the cell for posttranslational protein sulfation (Haila et al., 2001; Satoh et al., 1998) . The molecular basis of MED remains unknown in ∼15-20% of the cases.
All of the proteins encoded by the known MED-associated genes are involved in maintaining the structural integrity of the cartilage ECM. For the autosomal dominant forms of MED, the mutations exert their phenotypic effect through a dominant negative mechanism, leading to reduced secretion of structurally abnormal proteins into the extracellular matrix as well as intracellular retention of the abnormal proteins within the rough endoplasmic reticulum (RER) (Blumbach et al., 2009; Blumbach, Niehoff, Paulsson, & Zaucke, 2008; Chen, Posey, Hecht, & Vertel, 2008; Cotterill et al., 2005; Fresquet, Jackson, Loughlin, & Briggs, 2008) . In addition to disrupting the matrix, accumulation of abnormal proteins within the RER can induce an unfolded protein response and lead to secondary abnormalities, including chondrocyte apoptosis (Nundlall et al., 2010; Piróg-Garcia et al., 2007) . Mutations in SLC26A2 result in reduced activity of the sulfate transporter, which ultimately leads to decreased sulfation of proteins, particularly chondroitin sulfate proteoglycans, and negatively affects the ECM (Hastbacka et al., 1996; Rossi et al., 1998) .
In this study, exome sequencing followed by candidate gene analysis was used to search for the molecular basis of MED in cases without a mutation in a known gene. In two families in which there was recurrence of MED, homozygosity for pathogenic mutations was identified in CANT1, the gene encoding calcium-activated nucleotidase
1. The data demonstrate that the spectrum of allelic conditions due to mutations in CANT1 includes a second, recessively inherited form of MED that is clinically distinct from the allelic but more severe Desbuquois dysplasia (OMIM 613165) phenotype.
| MATERIALS AND METHODS

| Patients
All patient samples were obtained through the International Skeletal Dysplasia Registry (ISDR) at the University of California, Los Angeles.
Written informed consent was provided by all subjects under an approved Institutional Review Board (IRB) protocol. The two families included in this study have International Skeletal Dysplasia Registry reference numbers R92-280 and R01-152. DNA was isolated (Qiagen) from whole blood or Epstein Barr Virus transformed patient lymphoblastoid cell lines. All methods employed in this study were approved under a UCLA Biosafety protocol.
| Homozygosity mapping
Homozygosity mapping to identify runs of homozygosity (ROH) was conducted for the affected siblings in family R92-280 (cases R92-280A and R92-280B) using genome-wide single nucleotide polymorphism (SNP) array data. Shared ROH regions between the siblings were used for downstream data analysis.
| Exome sequencing
Exome sequencing was performed at the University of Washington Center for Mendelian Genomics (UWCMG). Exome libraries were prepared and 100 bp paired-end read sequences were derived using the Illumina platform. Sequence data were aligned to the Human GRCh37 reference genome using the Burrows Wheelers Aligner (BWA) MEM algorithm (Li, 2012) , and reads were de-duplicated using Picard. All further data processing was completed as published using the Genome Analysis Tool Kit (GATK) (McKenna et al., 2010) . All libraries had a depth of coverage of >20× for at least 90% of the targeted bases. Bam files were then recalibrated and realigned around the insertions and deletions and variant calling was conducted using
UnifiedGenotyper. Variant quality was assessed using the Variant Quality Score Recalibration tool with a general linearized model for both SNPs and indels.
A multisample VCF was generated and annotated using the SeattleSeq variant annotation server (Ng et al., 2009 ). The returned annotation file was saved to a SQL database and merged with the VCF.
All variants not targeting the exome or splice junction consensus sequences were excluded. Variant filtering was conducted under a recessive model both across the entire dataset and in combination with the ROH regions identified by homozygosity mapping in family R92-280.
| Sanger sequence and candidate gene analysis
PCR products for Sanger sequence analysis were generated using Qiagen Hotstart Taq DNA polymerase and touchdown PCR. PCR primers were designed using Primer3 software (Koressaar & Remm, 2007; Untergasser et al., 2012) . CANT1 primers were designed to include all coding exon(s) and 20 bp flanking the intron-exon splice junctions with the exception of the first coding exon (exon 3; transcript NM_001159773.1), which was amplified in two PCR products with overlapping regions covering approximately 30-40 bp in the middle of the exon. PCR and sequencing primer sequences can be found in Supplemental Table SI . Variants identified by exome sequencing were confirmed by Sanger sequence analysis of PCR products, in both the forward and reverse directions, with the sequences analyzed using Sequencher 2.0. Sequences were aligned to the GRCh37 reference sequence on the UC Santa Cruz Genome Browser (Kent et al., 2002) .
Candidate gene mutation screening of CANT1 in family R01-152 was conducted using bidirectional sequence analysis of PCR products of the coding exons.
| RESULTS
To identify the molecular basis of MED in a family (R92-280) with recurrence of the phenotype, exome sequence analysis was carried out for the two affected siblings and their parents ( Figure 1 ). The exome sequences of the affected individuals (R92-280A and R92-280B) were first filtered for variants in the known MED loci, excluding all six genes and indicating that MED in the family is likely to result from a mutation at a distinct locus. Genome wide SNP array data (not shown) identified two large ROH regions shared by the two affected individuals, consistent with unknown ancestral consanguinity between the parents and a recessively inherited phenotype due to homozygosity for a mutation inherited identically by descent. The exome data were therefore filtered to identify all missense, nonsense, and splicing Ile171Phe variant in the gene and the possibility that MED in the family is allelic to the more severe DBQD chondrodysplasia phenotype.
The CANT1 p.Ile171Phe missense variant was absent in dbSNP, the Exome Sequencing Project (ESP) database, and the ExAC database.
The variant was predicted to be "possibly damaging" by PolyPhen From the ISDR archive, we identified four additional unsolved MED cases with the "Swedish key" radiographic appearance of the proximal femurs, and used Sanger sequence analysis to screen CANT1 for variants. In one case, R01-152A, homozygosity for the CANT1 missense variant p.Val226Met was identified. This is a known pathogenic mutation that has primarily been observed in the compound heterozygous state in cases with the DBQD Kim variant (Furuichi et al., 2011) .
The radiographic phenotype of MED patient R01-152 had some overlapping features with DBQD, including degenerative arthrosis of the hand and spine by 25 years of age (Figure 2 ), but the overall phenotype was milder and clearly distinct from DBQD (Table 2) .
| DISCUSSION
Recessively inherited mutations in CANT1 were identified in two recurrent cases of MED. Mutations in CANT1 are known to cause Desbuquois dysplasia (DBQD), which is characterized by severe short stature, joint dislocations, scoliosis, advanced carpal, and tarsal ossification, accessory ossification centers in the hand, and a characteristic "Swedish key" appearance of the proximal femur on radiographs (Huber et al., 2009 ). The DBQD phenotypic spectrum comprises three clinically distinct entities. Type I and Type II DBQD are distinguished based on the presence or absence of the accessory ossification centers distal to the second metacarpal, or a delta phalanx (Faivre et al., 2004) , and the DBQD Kim variant is clinically distinguished by a milder overall phenotype and short metacarpals with relatively elongated phalanges (Kim et al., 2010) . While the MED patients in our cohort were selected based on presence of a "Swedish key" appearance of the proximal femurs, they were of mild short stature and did not have joint dislocations, distinguishing the MED phenotype from DBQD I and II. Furthermore, their hands were radiographically normal, with no evidence of either short metacarpals or elongated phalanges, distinguishing the phenotype from the DBQD Kim variant. Thus the MED phenotype due to CANT1 mutations is clinically distinct from all forms of DBQD and expands the phenotypic spectrum associated with mutations in the gene to include a second, recessively inherited form of MED.
Homozygosity for the p.Val226Met missense mutation was identified in case R01-152A. The p.Val226Met mutation lies in the fourth nucleotide conserved region and it has been demonstrated to reduce CANT1 nucleotidase activity to about 20% of the wild-type enzyme activity (Furuichi et al., 2011) . Eight families with the milder Kim variant have been reported to date, and four of these cases result here have not been published (Furuichi et al., 2011; Kim et al., 2010) .
Prior to this study the p.Val226Met variant has only been identified in individuals of Japanese and Korean ethnicity (Dai et al., 2011; Furuichi et al., 2011) . As the MED family was of Latino ancestry, the same mutation may have occurred independently in this ethnic group. The UMP is normally exchanged for UDP-sugars, which are required for the synthesis and elongation of GAG chains (Nizon et al., 2012) .
Based on this function, we suggest that CANT1 MED mutations have a milder but similar indirect effect on extracellular matrix (ECM) biosynthesis, as many ECM proteins have GAG posttranslational modifications that may depend on wild-type CANT1 activity. It is not clear, however, whether the phenotype results from a general effect on multiple posttranslationally modified proteins or is due to defects in the mature form of one or a few proteins.
In conclusion, exome sequencing and candidate gene analysis identified homozygosity for recessively inherited mutations in CANT1 in two families with recurrent MED. The phenotype has some similarity to the allelic forms of DBQD, but the observed clinical and radiographic phenotype was clinically distinct, identifying CANT1 as a second locus for a recessively inherited form of MED. 
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